Orphan Drugs in Development for the Treatment of Friedreich’s Ataxia: Focus on Omaveloxolone
Degenerative Neurological and Neuromuscular Disease
doi 10.2147/dnnd.s180027
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Informa UK Limited